March 9, 2006 (San Francisco) — The largest and arguably most complex risk-management program ever undertaken by the US Food and Drug Administration is sparking a commensurate measure of controversy — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback